Metastatic Colon Cancer Completed Phase 1 Trials for Cetuximab (DB00002)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00134069Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerTreatment
NCT00397384Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerTreatment
NCT01294826Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerTreatment